학술논문
Hepatitis C drug prescriptions and Medicaid policies--four states, Indian health care system, USA 2018
Document Type
article
Source
International Journal for Equity in Health, Vol 18, Iss 1, Pp 1-3 (2019)
Subject
Language
English
ISSN
1475-9276
Abstract
Abstract Medicaid, the state-level public insurance in the United States, has widely differing criteria treatment for hepatitis C virus (HCV) such as stage of liver fibrosis, documented sobriety, and specialist consultation. In a rural health network, facilities located in two less restrictive states prescribed HCV drugs at a significantly higher rate than two more restrictive states (rate ratio 4.7, CI 2.6–8.5). Prescription rates per population were highly associated with HCV treatment policies.